Nationalität
USA
Geburtsjahr
1966
Massachusetts Institute of Technology, M.Sc. in Management; M.Sc.in Chemieingenieurwesen (Biochemical Processing)
University of Texas, Austin, Texas B. S. in Chemieingenieurwesen
1989
Prozessingenieur Forschung & Entwicklung, Ethyl Corporation, Den Haag, Niederlande
1990
Line Supervisor, Ethyl Corporation, Brüssel, Belgien
1995
Marketing Manager, Display Products Venture, Raychem Corporation, San Francisco Bay Area, USA
1997
Business Planning Manager, Biogen, Cambridge, Massachusetts, USA
1999
Managing Director, Vereinigtes Königreich und Irland, Biogen, London, UK
2001
Vice President of Finance, Business Planning, Biogen Idec., Cambridge, Massachusetts, USA
2004
Vice President und General Manager, Geschäftseinheit Neurologie, Biogen Idec., USA
2006
Senior Vice President, Geschäftseinheit Immunologie und Ophthalmologie, Genentech, USA
2010
Senior Vice President, Geschäftseinheit BioOnkology, Genentech, USA
2013
Head of Global Product Strategy / Chief Marketing Officer, Roche Pharmaceuticals, Basel, Schweiz
2016
Leiter North American Operations Genentech, USA
2017-2018
Chief Executive Officer, Genentech, USA
2019-heute
CEO Roche Pharmaceutical
2019-heute
Chugai Pharmaceuticals
FHI (Flatiron Health, Inc.)
FMI (Foundation Medicine, Inc.)
GNE (Genentech, Inc.)
Spark Therapeutics
2017-2018: BIO (Biotechnology Innovation Organization)
2019-2020: PhRMA (Pharmaceutical Research and Manufacturers of America)
Januar 2021-heute: European Federation of Pharmaceuticals Industries and Associations
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.